• Home
  • About Us
    Company ProfileMilestonesCSRContact Us
  • Product Solutions
    Structural Heart SolutionsPeripheral Vascular SolutionsProduct Manuals
  • Research & Development
  • News
    Company News
  • Investor Relations
    Stock InformationAnnouncements & Financial ReportsCorporate GovernanceIR Contacts
  • Join Us
中文

Investor Relations

Announcements
Year
  • All
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
2025
2025
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • View / Download
    2025 / 04 / 25

    Proxy Form for use at the Annual General Meeting to be held on Wednesday, 28 May 2025 or any adjournment thereof

  • View / Download
    2025 / 04 / 25

    GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF DIRECTORS AND CONTINUOUS APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND (3) NOTICE OF ANNUAL GENERAL MEETING

  • View / Download
    2025 / 04 / 17

    Dissemination of Corporate Communications

  • View / Download
    2025 / 04 / 07

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025

  • View / Download
    2025 / 03 / 28

    ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024

  • View / Download
    2025 / 03 / 21

    Voluntary Announcement - Pre-market Clinical Trial of LAmbreTM Plus Left Atrial Appendage Closure System Obtained Medical Insurance Coverage in the US

  • View / Download
    2025 / 03 / 10

    NOTICE OF BOARD MEETING

  • View / Download
    2025 / 03 / 05

    MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025

  • View / Download
    2025 / 02 / 27

    DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF PRINCIPAL-PROTECTED STRUCTURED DEPOSIT

  • View / Download
    2025 / 02 / 12

    Voluntary Announcement - AnkuraTM Aortic Stent Graft System Obtained Official Registration Approval from the China NMPA

  • ·
  • 1
  • 2
  • 3
  • ·
14F, LifeTech Scientific Building, Keji 12th Road South, High-tech Industrial Park, Nanshan District, Shenzhen City, Guangdong Province, 518063, PRC
  • Tel:+86 755 86026250
  • Fax:+86 755 86026251
  • About Us
    Company Profile Milestones CSR Contact Us
  • Product Solutions
    Structural Heart Solutions Peripheral Vascular Solutions Product Manuals
  • Research & Development
  • News
    Company News
  • Investor Relations
    Stock Information Announcements & Financial Reports Corporate Governance IR Contacts
  • Join Us
Last Updated
Legal Statement Privacy Policy
© 2008-2025 LifeTech Scientific Corporation All rights reserved.